{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:01:49Z","timestamp":1760266909839},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Molecular Biology"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.jmb.2008.07.062","type":"journal-article","created":{"date-parts":[[2008,7,30]],"date-time":"2008-07-30T08:17:55Z","timestamp":1217405875000},"page":"347-357","source":"Crossref","is-referenced-by-count":17,"title":["Structural and Kinetic Analysis of Pyrrolidine-Based Inhibitors of the Drug-Resistant Ile84Val Mutant of HIV-1 Protease"],"prefix":"10.1016","volume":"383","author":[{"given":"Jark","family":"B\u00f6ttcher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Blum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Heine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wibke E.","family":"Diederich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Klebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmb.2008.07.062_bib1","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1146\/annurev.bi.62.070193.002551","article-title":"Structure-based inhibitors of HIV-1 protease","volume":"62","author":"Wlodawer","year":"1993","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jmb.2008.07.062_bib2","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1126\/science.2420008","article-title":"HTLV-III gag protein is processed in yeast cells by the virus pol-protease","volume":"231","author":"Kramer","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.jmb.2008.07.062_bib3","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1073\/pnas.85.13.4686","article-title":"Active human immunodeficiency virus protease is required for viral infectivity","volume":"85","author":"Kohl","year":"1988","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jmb.2008.07.062_bib4","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/nrd2336","article-title":"HIV drug development: the next 25\u00a0years","volume":"6","author":"Flexner","year":"2007","journal-title":"Nat. Rev., Drug Discov."},{"key":"10.1016\/j.jmb.2008.07.062_bib5","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1097\/00002030-200107270-00006","article-title":"Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults","volume":"15","author":"Bartlett","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.jmb.2008.07.062_bib6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.7326\/0003-4819-133-1-200007040-00007","article-title":"3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine","volume":"133","author":"Gulick","year":"2000","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jmb.2008.07.062_bib7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1126\/science.7824947","article-title":"HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy","volume":"267","author":"Coffin","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.jmb.2008.07.062_bib8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2174\/1389200043335522","article-title":"Resistance to HIV protease inhibitors: mechanisms and clinical consequences","volume":"5","author":"Mendoza","year":"2004","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jmb.2008.07.062_bib9","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.biocel.2004.02.021","article-title":"Thermodynamic rules for the design of high affinity HIV-1 protease inhibitors with adaptability to mutations and high selectivity towards unwanted targets","volume":"36","author":"Ohtaka","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jmb.2008.07.062_bib10","first-page":"21","article-title":"Drug resistance mutations in HIV-1","volume":"10","author":"D'Aquila","year":"2002","journal-title":"Top. HIV Med."},{"key":"10.1016\/j.jmb.2008.07.062_bib11","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1002\/anie.200462643","article-title":"An old target revisited: two new privileged skeletons and an unexpected binding mode for HIV-protease inhibitors","volume":"44","author":"Specker","year":"2005","journal-title":"Angew. Chem., Int. Ed."},{"key":"10.1016\/j.jmb.2008.07.062_bib12","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1021\/jm701142s","article-title":"Structure guided design of C2-symmetric HIV-1 protease inhibitors based on a pyrrolidine scaffold","volume":"51","author":"Blum","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2008.07.062_bib13","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1073\/pnas.92.7.2484","article-title":"ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in Humans","volume":"92","author":"Kempf","year":"1995","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jmb.2008.07.062_bib14","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.1021\/bi051886s","article-title":"Analysis of HIV-1 CRF_01 A\/E protease inhibitor resistance: structural determinants for maintaining sensitivity and developing resistance to atazanavir","volume":"45","author":"Clemente","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2008.07.062_bib15","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1021\/jm049560p","article-title":"Discovery and selection of TMC114, a next generation HIV-1 protease inhibitor","volume":"48","author":"Surleraux","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2008.07.062_bib16","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1021\/ja00108a056","article-title":"Crystal structure of HIV-1 protease in complex with VX-478, a potent and orally bioavailable inhibitor of the enzyme","volume":"117","author":"Kim","year":"1995","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmb.2008.07.062_bib17","doi-asserted-by":"crossref","first-page":"26344","DOI":"10.1016\/S0021-9258(18)47199-2","article-title":"Crystal structure at 1.9-\u00c5 resolution of human immunodeficiency virus (HIV) II protease complexed with L-735,524, an orally bioavailable inhibitor of the HIV proteases","volume":"269","author":"Chen","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2008.07.062_bib18","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1021\/jm9704098","article-title":"Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease","volume":"40","author":"Kaldor","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2008.07.062_bib19","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1021\/jm00115a028","article-title":"Novel binding mode of highly potent HIV-proteinase inhibitors incorporating the (R)-hydroxyethylamine isostere","volume":"34","author":"Krohn","year":"1991","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2008.07.062_bib20","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1128\/JVI.02706-06","article-title":"Unique thermodynamic response of tipranavir to human immunodeficiency virus type 1 protease drug resistance mutations","volume":"81","author":"Muzammil","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2008.07.062_bib21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2165\/00044011-200020040-00008","article-title":"Resistance to the HIV protease inhibitor amprenavir in vitro and in clinical studies: a review","volume":"20","author":"Tisdale","year":"2000","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.jmb.2008.07.062_bib22","doi-asserted-by":"crossref","first-page":"17979","DOI":"10.1074\/jbc.271.30.17979","article-title":"Kinetic characterization of human immunodeficiency virus type-1 protease-resistant variants","volume":"271","author":"Pazhanisamy","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2008.07.062_bib23","doi-asserted-by":"crossref","first-page":"8735","DOI":"10.1021\/bi972555l","article-title":"Resistance to HIV protease inhibitors: a comparison of enzyme inhibition and antiviral potency","volume":"37","author":"Klabe","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2008.07.062_bib24","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/prot.21304","article-title":"Atomic resolution crystal structures of HIV-1 protease and mutants V82A and I84V with saquinavir","volume":"67","author":"Tie","year":"2007","journal-title":"Proteins"},{"key":"10.1016\/j.jmb.2008.07.062_bib25","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1021\/jm070482q","article-title":"Potent new antiviral compound shows similar inhibition and structural interactions with drug resistant mutants and wild type HIV-1 protease","volume":"50","author":"Wang","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2008.07.062_bib26","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1110\/ps.0206402","article-title":"Overcoming drug resistance in HIV-1 chemotherapy: the binding thermodynamics of amprenavir and TMC-126 to wild-type and drug-resistant mutants of the HIV-1 protease","volume":"11","author":"Ohtaka","year":"2002","journal-title":"Protein Sci."},{"key":"10.1016\/j.jmb.2008.07.062_bib27","doi-asserted-by":"crossref","first-page":"11876","DOI":"10.1021\/bi001013s","article-title":"Thermodynamic basis of resistance to HIV-1 protease inhibition: calorimetric analysis of the V82F\/I84V active site resistant mutant","volume":"39","author":"Todd","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2008.07.062_bib28","doi-asserted-by":"crossref","first-page":"14937","DOI":"10.1073\/pnas.251265598","article-title":"Computational study of protein specificity: the molecular basis of HIV-1 protease drug resistance","volume":"98","author":"Wang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jmb.2008.07.062_bib29","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1126\/science.2448875","article-title":"Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase","volume":"239","author":"Saiki","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.jmb.2008.07.062_bib30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF00178172","article-title":"High-level expression and purification of mature HIV-1 protease in Escherichia coli under control of the araBAD promoter","volume":"37","author":"Taylor","year":"1992","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.jmb.2008.07.062_bib31","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1399-3011.1990.tb00994.x","article-title":"A simple, continuous fluorometric assay for HIV protease","volume":"36","author":"Toth","year":"1990","journal-title":"Int. J. Pept. Protein Res."},{"key":"10.1016\/j.jmb.2008.07.062_bib32","first-page":"307","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"Vol. 276","author":"Otwinowski","year":"1997"},{"key":"10.1016\/j.jmb.2008.07.062_bib33","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1107\/S0907444903028956","article-title":"Likelihood-enhanced fast rotation functions","volume":"60","author":"Storoni","year":"2004","journal-title":"Acta Crystallogr., Sect. D: Biol. Crystallogr."},{"key":"10.1016\/j.jmb.2008.07.062_bib34","first-page":"319","article-title":"SHELXL: high-resolution refinement","volume":"Vol. 277","author":"Sheldrick","year":"1997"},{"key":"10.1016\/j.jmb.2008.07.062_bib35","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr., Sect. D: Biol. Crystallogr."},{"key":"10.1016\/j.jmb.2008.07.062_bib36","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/jm00145a002","article-title":"A computational procedure for determining energetically favorable binding sites on biologically important macromolecules","volume":"28","author":"Goodford","year":"1985","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2008.07.062_bib37","series-title":"The PyMOL Molecular Graphics System","author":"DeLano","year":"2002"},{"key":"10.1016\/j.jmb.2008.07.062_bib38","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1107\/S0021889883010985","article-title":"Analytical molecular surface calculation","volume":"16","author":"Connolly","year":"1983","journal-title":"J. Appl. Crystallogr."}],"container-title":["Journal of Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283608009315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283608009315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T02:23:33Z","timestamp":1631586213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022283608009315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0022283608009315"],"URL":"https:\/\/doi.org\/10.1016\/j.jmb.2008.07.062","relation":{},"ISSN":["0022-2836"],"issn-type":[{"value":"0022-2836","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}